(redirected from adenocarcinoma in situ)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for adenocarcinoma

malignant tumor originating in glandular epithelium

References in periodicals archive ?
Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix.
7 Adicionalmente, el 0-8% de pacientes con diagnostico de AGC en la citologia tendran una biopsia que confirma adenocarcinoma in situ (AIS) y 1-9% tendra diagnostico de carcinoma invasivo.
An additional comment by the pathologist suggested that endocervical glandular dysplasia or adenocarcinoma in situ could not be ruled out.
A and B, Endometriosis mimicking endocervical adenocarcinoma in situ (AIS) in a cervical biopsy.
However, in FUTURE I, when the groups comprising HPV-naive and HPV-positive subjects and those with and without preexisting neoplasia were combined, the vaccine was 20% effective in preventing CIN 2,3, adenocarcinoma in situ, and cervical cancer, and 34% effective in preventing genital warts and vulvar and vaginal intraepithelial neoplasia and cancer due to vaccine and nonvaccine HPV types.
SAN DIEGO -- Close surveillance of cervical adenocarcinoma in situ is an option, but only for women with negative margins who want to preserve their fertility, researchers cautioned at the annual meeting of the Society of Cynecologic Oncologists.
SAN DIEGO -- Close surveillance of cervical adenocarcinoma in situ is an option but only for young women with negative margins who want to preserve their fertility, cautioned researchers at the annual meeting of the Society of Gynecologic Oncologists.
Cervical glandular neoplasia, including adenocarcinoma in situ (AIS) and invasive adenocarcinoma, is less common than squamous neoplasia.
Adenocarcinoma in situ is defined as a small ([less than or equal to] 3 cm) solitary adenocarcinoma with pure lepidic growth and no stromal, vascular, or pleural invasion.
2) Furthermore, PAX8 was expressed in 97% to 100% of adenocarcinoma in situ (AIS) and in 0% to 87% of endocervical adenocarcinoma (ECA) specimens (summarized in Table 1).
As we have over the decades come to better understand lung neoplasia and preneoplasia, bronchioloalveolar carcinoma (far from being understood as a single, specific lesion as it was originally considered) has leant its appellation to 5 clinically and pathologically distinct entities, namely, 3 nonmucinous lesions (adenocarcinoma in situ, minimally invasive adenocarcinoma, and adenocarcinoma with a prominent lepidic pattern) and 2 mucinous lesions (mucinous adenocarcinoma in situ and mucinous adenocarcinoma).
Combining the most clinically significant cytologic abnormalities of high-grade squamous intraepithelial lesion, adenocarcinoma in situ, and carcinoma, the highest reporting rates were with SurePath and ThinPrep (0.
Adenocarcinoma in situ (AIS) is a well-known precursor of invasive cervical adenocarcinoma.
1) Lung adenocarcinoma in situ (AIS, previously classified as bronchioloalveolar carcinoma) and invasive adenocarcinoma with mucinous histology have been classically described in the setting of congenital pulmonary airway malformation, primarily in type 1 malformations.